{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:30:47Z","timestamp":1760297447863},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,9,1]],"date-time":"1993-09-01T00:00:00Z","timestamp":746841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1007\/bf01518451","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T22:58:33Z","timestamp":1113865113000},"page":"293-298","source":"Crossref","is-referenced-by-count":62,"title":["Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2"],"prefix":"10.1007","volume":"37","author":[{"given":"Rhona","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Belisle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1073\/pnas.89.21.10242","volume":"89","author":"A Aruffo","year":"1992","unstructured":"Aruffo A, Kanner SB, Sgroi D, Ledbetter JA, Stamenkovic I (1992) CD22-mediated stimulation of T cells regulates T-cell receptor\/CD3-induced signaling. Proc Natl Acad Sci USA 89: 10242","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","first-page":"903","volume":"33","author":"W Becker","year":"1992","unstructured":"Becker W, Lsuer U, Marienhagen J, Goldenberg DM, Wolf F (1992) Comparison of Tc-99m-antigranulocyte (NCA-95) Fab?-fragments and scintigraphy with In-111-oxin\/Tc-99m-HMPAO-labelled leukocytes in infectious diseases. J Nucl Med 33: 903","journal-title":"J Nucl Med"},{"key":"CR3","first-page":"6476","volume":"52","author":"DJ Buchsbaum","year":"1992","unstructured":"Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS (1992) Therapy with unlabeled and131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts. Cancer Res 52:6476","journal-title":"Cancer Res"},{"issue":"Suppl","key":"CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.2910410819","volume":"3","author":"SJ DeNardo","year":"1988","unstructured":"DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL (1988) Treatment of B cell malignancies with131I Lym-1 monoclonal antibodies. Int J Cancer [Suppl] 3: 96","journal-title":"Int J Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.136.12.4470","volume":"136","author":"B Dorken","year":"1986","unstructured":"Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM (1986) HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136: 4470","journal-title":"J Immunol"},{"key":"CR6","first-page":"63","volume-title":"Leukocyte typing, IV","author":"B Dorken","year":"1989","unstructured":"Dorken B, Moller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G (1989) B-cell antigens: CD22. In: Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGKr (eds) Leukocyte typing, IV. Oxford University Press, Oxford, p 63"},{"key":"CR7","first-page":"2610","volume":"48","author":"M-A Ghetie","year":"1988","unstructured":"Ghetie M-A, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, Amlot P, Vitetta ES, Thorpe PE (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res 48: 2610","journal-title":"Cancer Res"},{"key":"CR8","first-page":"5876","volume":"51","author":"M-A Ghetie","year":"1991","unstructured":"Ghetie M-A, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES (1991) Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Res 51: 5876","journal-title":"Cancer Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0001-2998(89)80025-X","volume":"19","author":"DM Goldenberg","year":"1989","unstructured":"Goldenberg DM (1989) Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Semin Nucl Med 19: 332","journal-title":"Semin Nucl Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.1991.9.4.548","volume":"9","author":"DM Goldenberg","year":"1991","unstructured":"Goldenberg DM, Horowitz JA, Sharkey RM, Hall TC, Murthy S, Goldenberg H, Lee RE, Stein R, Siegel JA, Izon DO, Burger K, Swayne L, Belisle E, Hansen HJ, Pinsky CM (1991) Targeting, dosimetry and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol 9: 548","journal-title":"J Clin Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.2910230206","volume":"23","author":"R Hurwitz","year":"1979","unstructured":"Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, Kubonishi I, Kersey J (1979) Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 23: 174","journal-title":"Int J Cancer"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1200\/JCO.1992.10.11.1696","volume":"10","author":"MS Kaminski","year":"1992","unstructured":"Kaminski MS, Fig LM, Zasadny KR, Koral KF, DelRosario RB, Francis IR, Hanson CA, Normolle DP, Mudgett E, Liu CP, Moon S, Scott P, Miller RA, Wahl RL (1992) Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. J Clin Oncol 10: 1696","journal-title":"J Clin Oncol"},{"key":"CR13","first-page":"345","volume":"5","author":"MS Kaminski","year":"1992","unstructured":"Kaminski MS, Zasadny KR, Moon S, Roesner J, Milik AW, Butchko G, Glenn S, Wahl RL (1992) Initial clinical radioimmunotherapy results with 131-I-anti-B1 (anti-CD20) in refractory B-cell lymphoma. Antibody Immunoconjugate Radiopharmacol 5: 345","journal-title":"Antibody Immunoconjugate Radiopharmacol"},{"key":"CR14","first-page":"819","volume":"53","author":"RJ Kreitman","year":"1993","unstructured":"Kreitman RJ, Hansen HJ, Jones AL, FitzGerald DJP, Goldenberg DM, Pastan I (1993)Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice. Cancer Res 53: 819","journal-title":"Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0008-8749(89)90359-6","volume":"118","author":"J-L Li","year":"1989","unstructured":"Li J-L, Shen G-L, Ghetie M-A, May RD, Till M, Ghetie V, Uhr JW, Janossy G, Thorpe PE, Amlot P, Vitetta ES (1989) The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cellular Immunol 118: 85","journal-title":"Cellular Immunol"},{"key":"CR16","first-page":"342","volume":"33","author":"HH Lu","year":"1992","unstructured":"Lu HH, Shih LB, Xuan H, Goldenberg DM (1992) Internalization and cellular distribution of an anti-B-cell lymphoma antibody, LL2. Proc Am Assoc Cancer Res 33: 342","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000229699","volume":"29","author":"PJ McConahey","year":"1966","unstructured":"McConahey PJ, Dixon FJ (1966) A method of trace iodination of proteins for immunologic studies. Int Arch Allergy 29: 185","journal-title":"Int Arch Allergy"},{"key":"CR18","first-page":"891","volume":"49","author":"J Minowada","year":"1972","unstructured":"Minowada J, Ohnuma T, Moore GE (1972) Rosette-forming human lymphoid cell lines 1. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49: 891","journal-title":"J Natl Cancer Inst"},{"key":"CR19","first-page":"4568","volume":"49","author":"EJ Pawlak-Byczkowska","year":"1989","unstructured":"Pawlak-Byczkowska EJ, Hansen HJ, Dion AS, Goldenberg DM (1989) Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma. Cancer Res 49: 4568","journal-title":"Cancer Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4049\/jimmunol.138.1.98","volume":"138","author":"A Pezzutto","year":"1987","unstructured":"Pezzutto A, Dorken B, Moldenhauer G, Clark EA (1987) Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp130\/140. J Immunol 138: 98","journal-title":"J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.140.6.1791","volume":"140","author":"A Pezzutto","year":"1988","unstructured":"Pezzutto A, Rabinovitch PS, Dorken B, Moldenhauer G, Clark EA (1988) Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol 140: 1791","journal-title":"J Immunol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.1989.7.8.1027","volume":"7","author":"OW Press","year":"1989","unstructured":"Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn K, Fisher D, DeSantes K, Porter B, Kidd P, Thomas ED, Bernstein ID (1989) Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7: 1027","journal-title":"J Clin Oncol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(64)92345-1","volume":"1","author":"RJV Pulvertaft","year":"1964","unstructured":"Pulvertaft RJV (1964) Cytology of Burkitt's lymphoma. Lancet 1: 238","journal-title":"Lancet"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.1990.8.5.792","volume":"8","author":"DA Scheinberg","year":"1990","unstructured":"Scheinberg DA, Straus DJ, Yeh SD, Divgi C, Garin-Chesa P, Graham M, Pentlow K, Coit D, Oettgen HF, Old LJ (1990) A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. J Clin Oncol 8: 792","journal-title":"J Clin Oncol"},{"key":"CR25","first-page":"65","volume-title":"Leukocyte typing. IV","author":"R Schwartz-Albiez","year":"1989","unstructured":"Schwartz-Albiez R, Dorken B, Moldenhauer G (1989) The carbohydrate moiety of the CD22 antigen can be modulated by inhibitors of the glycosylation pathway. In: Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGKr (eds) Leukocyte typing. IV. Oxford University Press, Oxford, p 65"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0092-8674(91)90036-X","volume":"66","author":"I Stamenkovic","year":"1991","unstructured":"Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T (1991) The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and ?2-6 sialyltransferase, CD75, on B cells. Cell 66: 1133","journal-title":"Cell"},{"key":"CR27","doi-asserted-by":"crossref","unstructured":"Stein R, Basu A, Chen S, Shih LB, Goldenberg DM (1993) Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma momoclonal antibody. Int J Cancer (in press)","DOI":"10.1002\/ijc.2910550611"},{"key":"CR28","first-page":"32","volume":"49","author":"R Stein","year":"1989","unstructured":"Stein R, Chen S, Grossman W, Goldenberg DM (1989) Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res 49: 32","journal-title":"Cancer Res"},{"key":"CR29","first-page":"4052","volume":"51","author":"ES Vitetta","year":"1991","unstructured":"Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, Ghetie C, Uhr JW, Thorpe PE (1991) Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res 51: 4052","journal-title":"Cancer Res"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01518451\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01518451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01518451\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01518451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:15:04Z","timestamp":1683072904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01518451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["BF01518451"],"URL":"https:\/\/doi.org\/10.1007\/bf01518451","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}